{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:32:35Z","timestamp":1761291155740,"version":"3.37.3"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00347-024-02101-w","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T10:02:09Z","timestamp":1725530529000},"page":"842-844","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Panuveitis unter Dabrafenib\/Trametinib-Therapie bei malignem kutanem Melanom persistierend nach Therapieende","Panuveitis under dabrafenib\/trametinib treatment for malignant cutaneous melanoma persisting after completion of treatment"],"prefix":"10.1007","volume":"121","author":[{"given":"M.","family":"Sommer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4316-043X","authenticated-orcid":false,"given":"P.","family":"Werkl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Heidinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Peschaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hatzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"2101_CR1","doi-asserted-by":"publisher","first-page":"NP109","DOI":"10.1177\/1120672120962044","volume":"32","author":"M Brambati","year":"2022","unstructured":"Brambati\u00a0M, Giuffre\u00a0C, Marchese\u00a0A et\u00a0al (2022) A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib\/trametinib therapy for advanced melanoma. Eur J Ophthalmol 32:NP109\u2013NP113","journal-title":"Eur J Ophthalmol"},{"key":"2101_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000357060","volume":"4","author":"L Joshi","year":"2013","unstructured":"Joshi\u00a0L, Karydis\u00a0A, Gemenetzi\u00a0M et\u00a0al (2013) Uveitis as a\u00a0Result of MAP Kinase Pathway Inhibition. Case Rep Ophthalmol 4:279\u2013282","journal-title":"Case Rep Ophthalmol"},{"key":"2101_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/IIO.0000000000000434","volume":"62","author":"A Rali","year":"2022","unstructured":"Rali\u00a0A, Huang\u00a0Y, Yeh\u00a0S (2022) Cancer Immunotherapy and Uveitis: Balancing Anti-Tumor Immunity and Ocular Autoimmunity. Int Ophthalmol Clin 62:49\u201363","journal-title":"Int Ophthalmol Clin"},{"key":"2101_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.oftal.2018.01.008","volume":"93","author":"T Rueda-Rueda","year":"2018","unstructured":"Rueda-Rueda\u00a0T, Sanchez-Vicente\u00a0JL, Moruno-Rodriguez\u00a0A et\u00a0al (2018) Uveitis and serous retinal detachment secondary to systemic dabrafenib and trametinib. Arch Soc Esp Oftalmol 93:458\u2013462","journal-title":"Arch Soc Esp Oftalmol"},{"key":"2101_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12886-017-0541-0","volume":"17","author":"S Sarny","year":"2017","unstructured":"Sarny\u00a0S, Neumayer\u00a0M, Kofler\u00a0J et\u00a0al (2017) Ocular toxicity due to Trametinib and Dabrafenib. BMC Ophthalmol 17:146","journal-title":"BMC Ophthalmol"},{"key":"2101_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/09273948.2019.1695860","volume":"29","author":"N Woltsche","year":"2021","unstructured":"Woltsche\u00a0N, Kruger\u00a0MA, Weger\u00a0M et\u00a0al (2021) Intravitreal Steroid Treatment for Uveitis Associated with Dabrafenib and Trametinib for Metastatic Cutaneous Melanoma. Ocul Immunol Inflamm 29:845\u2013847","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-02101-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-024-02101-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-02101-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T15:04:23Z","timestamp":1729177463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-024-02101-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2101"],"URL":"https:\/\/doi.org\/10.1007\/s00347-024-02101-w","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"type":"print","value":"2731-720X"},{"type":"electronic","value":"2731-7218"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"28 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Sommer, P.\u00a0Werkl, C.\u00a0Singer, A.\u00a0Heidinger, T.\u00a0Peschaut, M.\u00a0Kruger, A.\u00a0Hatzmann und G.\u00a0Seidel geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}